Modern Medicine in Digital format

Covid-19 Related Modern Medicine in Digital format

Modern Medicine in Digital format for Covid-19 Related problems/products have single frequency or combo of frequencies corresponding either to the molar mass or equivalent scalar octave of the related products are masked in Algorithmic piano music.

More information regarding the products given the list below is given below the list.

List of Modern Medicine in Digital format for Covid-19 Related problems/products available at us for just Rs. 5000/- for any 5 sessions from given below for  30 doses per session (2 times a day for 15 days) in max 15 days.

1) Arginase Inhibitors Mix
2) Camostat-K11777
3) Camostat
4) Coronavirus Infection
5) Covid-19
6) Covid-19 Mix
7) EpiVacCorona Vaccine
8) Gastroenteritis
9) Hydroxychloroquine-Azithromycin
10) Severe Acute Respiratory Syndrome
11) Viral Infectious Disease
12) Viral Pneumonia
13) diABZI-Sting Agonists

More information regarding Covid-19 related frequencies list above

* Arginase Inhibitors Mix. Arginine is an amino acid that has been shown in nonclinical studies to be essential in the life cycle of many viruses. Therefore, arginine depletion may be an effective therapeutic approach against SARS-CoV-2. In addition to the putative direct antiviral activity with regard to SARS-COV-2, arginine depletion may also attenuate the pulmonary inflammation seen in COVID-19. Severe cases of COVID-19 are characterized by a hyperinflammatory lung pathology and local tissue damage that contribute to poor patient outcome. Several arginine-metabolizing enzymes in clinical development may be a viable approach to induce a low arginine environment to treat COVID-19 and other viral diseases produced by the families Herpesviridae and Adenoviridae. In tumor biology and medicinal chemistry arginase exerts its immunosuppressive effect by depleting the amino acid arginine in the tumor microenvironment and preventing the immune system’s cytotoxic T-cells and natural killer (NK) cells from proliferating and killing the tumor. Inhibition of arginase activity reverses this immunosuppressive block and restores T-cell function. Arginase contributes to atherosclerosis and microvascular endothelial dysfunction in obesity. Its impact is reduced by aging because of higher levels of vascular oxidative stress. Obesity is accompanied by accelerated microvascular remodeling, the extent of which is related to the amount of arginase in the vascular wall. Small-molecule arginase inhibitors are currently described as promising therapeutic agents for the treatment of variety of diseases, including diseases associated with pathogens, ulcerative colitis, inflammatory bowel disease, allergic asthma, cardiovascular diseases, immune disorders, and cancer. The recording plays simultaneously the sound frequencies of Arginase Inhibitor 1, CB-1158-analog, CB-1158 (dihydrochloride), and 2(S)-amino-6-boronohexanoic acid (ABH). WARNING: Do not play this in the vicinity of either cats or kittens.

* Camostat-K11777. The transmembrane serine protease, TMPRSS2 is an important target in the treatment of seasonal influenza infections and contributes to prostate carcinogenesis and metastasis. TMPRSS2 inhibition is also used in the treatment of some forms of cancer and is effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis. Recent research has found that Camostat inhibition of TMPRSS2 partially blocked infection by SARS-CoV and Human coronavirus NL63 in HeLa cells. Another in vitro study showed that Camostat reduces significantly the infection of Calu-3 lung cells by SARS-CoV-2, the virus responsible for COVID-19. Viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by Camostat. Camostat has been clinically used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections. Camostat, or similar serine protease inhibitors, might be an effective option for treatment of SARS and potentially MERS, while vinyl sulfone-based inhibitors are excellent lead candidates for Ebola virus therapeutics. Broad-Spectrum Antiviral K11777, a cysteine protease inhibitor, blocked infection when viral entry did not require activating serine proteases, as is the case with ebolavirus (EBOV). K11777 also fully inhibited coronavirus infection, but only when target cell lines lacking activating serine proteases were used. If cells expressed cell-surface serine proteases known to activate coronaviruses, both K11777 and a serine protease inhibitor, such as camostat were required for full inhibition.

* Camostat. The transmembrane serine protease, TMPRSS2 is an important target in the treatment of seasonal influenza infections and contributes to prostate carcinogenesis and metastasis. TMPRSS2 inhibition is also used in the treatment of some forms of cancer and is effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis. Recent research has found that Camostat inhibition of TMPRSS2 partially blocked infection by SARS-CoV and Human coronavirus NL63 in HeLa cells. Another in vitro study showed that Camostat reduces significantly the infection of Calu-3 lung cells by SARS-CoV-2, the virus responsible for COVID-19. Viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by Camostat. Camostat has been clinically used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections.

* Coronavirus Infection. Coronavirus infection symptoms depend on the type of coronavirus and how serious the infection is. If you have a mild to moderate upper-respiratory infection such as the common cold, your symptoms may include Runny nose Headache Cough Sore throat Fever Not feeling well overall Some coronaviruses can cause severe symptoms. The infections may turn into bronchitis and pneumonia, which cause symptoms such as Fever, which may be quite high if you have pneumonia Cough with mucus Shortness of breath Chest pain or tightness when you breathe and cough Severe infections are more common in people with heart or lung diseases, people with weakened immune systems, infants, and older adults. A recording based upon Malacards data on Genetic Superpathways (as of 3/27/2020).

* Covid-19.

* COVID-19 Mix Strictly to be used with head phones or ear phones.

WARNING: Contains Disulfiram, do not play the mix if you -or someone else around have been drinking alcohol in the past 24h.
WARNING: Contains Arginase inhibitors, do not play the mix in the vicinity of either cats or kittens.
Each item plays for 5m.

R.- Ozonated Saline Solution
L.- Arginase Inhibitors

R.- Triazavirin, Camostat-K11777, Scutellarin
L.- Nitric Oxide-Heliox Saline, Baicalin

R.- Lapatinib, Dasatinib, Pazopanib, Sitravatinib
L.- Sildenafil, Famotidine, Fenofibrate

R.- Ubiquinone, Ezetimibe, Evolocumab
L.- Apilimod-Vacuolin-1, GC376

R.- Bamlanivimab, Etesevimab
L.- Remdesivir, Molnupiravir, DMSO, Favipiravir

R.- Niclosamide, Proxalutamide, Tocilizumab, Budesonide
L.- Lopinavir, Ritonavir

R.- Evans blue, Lumacaftor, Sodium Lifitegrast
L.- Ivermectin, Disulfiram, Azithromycin

R.- Casirivimab
L.- Imdevimab

R.- Hesperetin, Nicotinamide, Glycyrrhizin
L.- Vitamin B12, Vitamin A, Zinc, Magnesium

* diABZI Sting Agonists. The drug diABZI - which activates the body's innate immune response - was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2. The findings suggest that diABZI could also treat other respiratory coronaviruses. The researchers found that diABZI potently inhibits SARS-CoV-2 infection of diverse strains, including variant of concern B.1.351, by stimulating interferon signaling. diABZI could be an effective treatment for SARS-CoV-2 that could prevent severe COVID-19 symptoms and the spread of infection. Additionally, since diABZI has been shown to inhibit human parainfluenza virus and rhinovirus replication in cultured cells, the STING agonist may be more broadly effective against other respiratory viruses.

* EpiVacCorona Vaccine is a peptide-based vaccine against COVID-19 developed by the VECTOR center of Virology. It consists of three chemically synthesized peptides (short fragments of a viral spike protein) that are conjugated to a large carrier protein. The vaccine is delivered via intramuscular route and aluminum hydroxide serves as an immunological adjuvant.

* Gastroenteritis. Gastroenteritis is a gastrointestinal system infectious disease that involves inflammation of the lining of the stomach and small and large intestines, which is caused by viruses, bacteria, or parasites. Chemicals and drugs also cause gastroenteritis. The symptoms include diarrhea, loss of appetite, nausea, vomiting, cramps, and discomfort in the abdomen.

* Hydroxychloroquine is used to treat systemic lupus erythematosus, rheumatic disorders like rheumatoid arthritis, porphyria cutanea tarda, and Q fever, and certain types of malaria. It is considered the first line treatment for systemic lupus erythematosus. Certain types of malaria, resistant strains, and complicated cases require different or additional medication. Hydroxychloroquine is being studied as an experimental treatment for coronavirus disease 2019 (COVID-19). Azithromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler's diarrhea, and certain other intestinal infections. It can also be used for a number of sexually transmitted infections, including chlamydia and gonorrhea infections. Along with other medications, it may also be used for malaria. A new controlled clinical study conducted by doctors in France shows that a combo of Hydroxychloroquine and Azithromycin (Z-Pak) cures 100% of coronavirus patients within 6 days of treatment.

* Severe Acute Respiratory Syndrome. Severe Acute Respiratory Syndrome is a Coronavirus infection that results in infection located in respiratory tract, has material basis in SARS coronavirus (SARS-CoV), which is transmitted by droplet spread of respiratory secretions, transmitted by ingestion of contaminated food, or transmitted by fomites. The infection has symptom fever, has symptom headache, has symptom body aches, has symptom dry cough, and has symptom hypoxia.

* Viral Infectious Disease. A viral disease (or viral infection, or infectious disease) occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells.

* Viral Pneumonia. A pneumonia is described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.